Oksana M. Veselova

3rd Cherepkovskaya Str, 15A
Moscow, MOW 121552, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Dietary bioactive compounds and inflammaging: Pro-inflammatory triggers and geroprotective countermeasures.

Dietary bioactive compounds and inflammaging: Pro-inflammatory triggers and geroprotective countermeasures.

Journal: Ageing research reviews

Published: April 22, 2026

The preconditioning effect of a structural analogue of apelin-12 in a rat model of acute myocardial infarction.

The preconditioning effect of a structural analogue of apelin-12 in a rat model of acute myocardial infarction.

Journal: Biomeditsinskaia khimiia

Published: November 10, 2025

Potential dietary geroprotectors and their impact on key mechanisms of aging.

Potential dietary geroprotectors and their impact on key mechanisms of aging.

Journal: Biogerontology

Published: April 30, 2025

Galanin Reduces Myocardial Ischemia/Reperfusion Injury in Rats with Streptozotocin Diabetes.

Galanin Reduces Myocardial Ischemia/Reperfusion Injury in Rats with Streptozotocin Diabetes.

Journal: Acta naturae

Published: September 16, 2024

The structural analogue of apelin-12 prevents energy disorders in the heart in experimental type 1 diabetes mellitus.

The structural analogue of apelin-12 prevents energy disorders in the heart in experimental type 1 diabetes mellitus.

Journal: Biomeditsinskaia khimiia

Published: June 28, 2024

Exogenous GalR2-specific peptide agonist as a tool for treating myocardial ischemia/reperfusion injury.

Exogenous GalR2-specific peptide agonist as a tool for treating myocardial ischemia/reperfusion injury.

Journal: Fundamental & clinical pharmacology

Published: March 11, 2023

The anti-ischemic and antioxidant activity of the pharmacological agonist of galanin receptor GalR2 and carnosine in in vitro and in vivo model systems

The anti-ischemic and antioxidant activity of the pharmacological agonist of galanin receptor GalR2 and carnosine in in vitro and in vivo model systems

Journal: Biomeditsinskaia khimiia

Published: June 19, 2022

Chimeric Agonist of Galanin Receptor GALR2 Reduces Heart Damage in Rats with Streptozotocin-Induced Diabetes.

Chimeric Agonist of Galanin Receptor GALR2 Reduces Heart Damage in Rats with Streptozotocin-Induced Diabetes.

Journal: Biochemistry. Biokhimiia

Published: May 09, 2022

Antioxidant Properties of Galanin and Its N-Terminal Fragments in in vitro and in vivo Oxidative Stress Modeling.

Antioxidant Properties of Galanin and Its N-Terminal Fragments in in vitro and in vivo Oxidative Stress Modeling.

Journal: Biochemistry. Biokhimiia

Published: May 04, 2021

The Mechanisms of Cardiac Protection Using a Synthetic Agonist of Galanin Receptors during Chronic Administration of Doxorubicin.

The Mechanisms of Cardiac Protection Using a Synthetic Agonist of Galanin Receptors during Chronic Administration of Doxorubicin.

Journal: Acta naturae

Published: June 02, 2020

[MeArg1, NLe10]-apelin-12: Optimization of solid-phase synthesis and evaluation of biological properties in vitro and in vivo.

[MeArg1, NLe10]-apelin-12: Optimization of solid-phase synthesis and evaluation of biological properties in vitro and in vivo.

Journal: Peptides

Published: January 01, 2020

Cardiometabolic efficacy and toxicological evaluation of a pharmacological galanin receptor agonist

Cardiometabolic efficacy and toxicological evaluation of a pharmacological galanin receptor agonist

Journal: Biomeditsinskaia khimiia

Published: July 02, 2019

Showing 1-12 of 30

Last Updated: 09/26/2026